Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC

14th Sep 2020 12:03

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing11 September 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

 

 

 

 

2,206,099

1.71%

466,379

0.36%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

355,000

0.28%

393,389

0.31%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

TOTAL:

 

 

 

 

2,561,099

1.99%

859,768

0.67%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

5

206.4100 USD

Purchase

14

206.2100 USD

Purchase

15

206.2450 USD

Purchase

21

205.4500 USD

Purchase

50

206.1800 USD

Purchase

100

207.8200 USD

Purchase

100

205.3800 USD

Purchase

101

206.2900 USD

Purchase

101

206.7225 USD

Purchase

150

206.9800 USD

Purchase

200

207.0376 USD

Purchase

200

206.5400 USD

Purchase

225

205.8322 USD

Purchase

237

205.6023 USD

Purchase

262

207.1259 USD

Purchase

300

206.3200 USD

Purchase

324

206.7485 USD

Purchase

325

206.7853 USD

Purchase

365

206.4091 USD

Purchase

529

206.6625 USD

Purchase

533

206.6145 USD

Purchase

568

206.2700 USD

Purchase

679

206.2461 USD

Purchase

944

206.5019 USD

Purchase

976

206.2798 USD

Purchase

1,101

206.2577 USD

Purchase

1,219

206.4551 USD

Purchase

2,016

206.3705 USD

Purchase

2,520

206.1200 USD

Purchase

2,956

206.3378 USD

Purchase

5,896

206.3074 USD

Purchase

6,904

206.2517 USD

Purchase

9,617

206.6323 USD

Purchase

10,088

206.4776 USD

Purchase

13,270

206.5648 USD

Purchase

131,219

206.6552 USD

Sale

8

206.4900 USD

Sale

8

206.6400 USD

Sale

36

206.7400 USD

Sale

53

206.1122 USD

Sale

85

206.8800 USD

Sale

100

206.9900 USD

Sale

100

204.6700 USD

Sale

110

206.4063 USD

Sale

121

206.5752 USD

Sale

144

206.5086 USD

Sale

150

206.6933 USD

Sale

162

206.5519 USD

Sale

185

206.9800 USD

Sale

262

206.7897 USD

Sale

300

206.2433 USD

Sale

300

206.8933 USD

Sale

758

206.1289 USD

Sale

975

206.2007 USD

Sale

1,100

206.3027 USD

Sale

1,257

206.8276 USD

Sale

1,548

206.1580 USD

Sale

2,345

206.2067 USD

Sale

2,353

206.1200 USD

Sale

2,494

206.4844 USD

Sale

3,500

206.8270 USD

Sale

4,000

207.0703 USD

Sale

4,466

206.3919 USD

Sale

5,005

206.5214 USD

Sale

5,261

206.1742 USD

Sale

6,346

206.2238 USD

Sale

6,441

206.4781 USD

Sale

6,462

206.6853 USD

Sale

8,061

206.5104 USD

Sale

8,387

206.7514 USD

Sale

8,500

206.6068 USD

Sale

8,664

206.8131 USD

Sale

9,261

206.7298 USD

Sale

10,525

206.5145 USD

Sale

12,845

206.3533 USD

Sale

16,656

206.6702 USD

Sale

52,104

206.7162 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

14 Sep 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005435/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value8,889.00
Change38.37